Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen K Bolon

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Infectious Disease Clinics of North America|November 14, 2009
The newer fluoroquinolonesMaureen K Bolon
Infectious Disease Clinics of North America|August 13, 2016
Hand Hygiene: An UpdateMaureen K Bolon
The Medical Clinics of North America|June 18, 2011
The newer fluoroquinolonesMaureen K Bolon
The Journal of Infection|September 24, 2014
Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistanceMargaret A Fitzpatrick, Egon Ozer, Maureen K Bolon, et al.
Infection Control and Hospital Epidemiology|March 8, 2014
Outcomes of an enhanced surveillance program for carbapenem-resistant EnterobacteriaceaeMargaret Fitzpatrick, Teresa Zembower, Michael Malczynski, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reportedMaureen K Bolon, Sharon B Wright, Howard S Gold, et al.
Infectious Disease Reports|September 11, 2020
An unusual case of <i>Staphylococcus pasteuri</i> osteomyelitisPhillip P Santoiemma, David M Kalainov, Manish P Mehta, et al.
The Journal of Antimicrobial Chemotherapy|February 10, 2009
Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysisMarc H Scheetz, Maureen K Bolon, Michael Postelnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysisMaureen K Bolon, Monica Morlote, Stephen G Weber, et al.
The Journal of Infection|May 21, 2005
Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemiaMarc H Scheetz, Maureen K Bolon, Kimberly K Scarsi, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Infectious Disease Clinics of North America|November 14, 2009
The newer fluoroquinolonesMaureen K Bolon
Infectious Disease Clinics of North America|August 13, 2016
Hand Hygiene: An UpdateMaureen K Bolon
The Medical Clinics of North America|June 18, 2011
The newer fluoroquinolonesMaureen K Bolon
The Journal of Infection|September 24, 2014
Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistanceMargaret A Fitzpatrick, Egon Ozer, Maureen K Bolon, et al.
Infection Control and Hospital Epidemiology|March 8, 2014
Outcomes of an enhanced surveillance program for carbapenem-resistant EnterobacteriaceaeMargaret Fitzpatrick, Teresa Zembower, Michael Malczynski, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reportedMaureen K Bolon, Sharon B Wright, Howard S Gold, et al.
Infectious Disease Reports|September 11, 2020
An unusual case of <i>Staphylococcus pasteuri</i> osteomyelitisPhillip P Santoiemma, David M Kalainov, Manish P Mehta, et al.
The Journal of Antimicrobial Chemotherapy|February 10, 2009
Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysisMarc H Scheetz, Maureen K Bolon, Michael Postelnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysisMaureen K Bolon, Monica Morlote, Stephen G Weber, et al.
The Journal of Infection|May 21, 2005
Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemiaMarc H Scheetz, Maureen K Bolon, Kimberly K Scarsi, et al.
Pageof 4